2 results
Approved WMOCompleted
The aim of the study is to assess the risk of impaired driving in the morning at 3 and 4 hours after a middle-of-the-night dose of zolpidem tartrate sublingual tablet 3.5 mg.
Approved WMOCompleted
Parts A and BPrimary objective• To investigate the inhibition of primary CNS effects of a THC challenge by CB1 receptor antagonist compared to placebo in healthy occasional users of cannabisSecondary objective• To investigate the inhibition of…